COMMUNIQUÉS West-GlobeNewswire

Des documents internes de l’ARC démontrent l’intention de refuser aux Canadiens atteints de diabète de type 1 l’accès au crédit d’impôt pour personnes handicapées

04/12/2017 - 16:00

OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- Diabète Canada et FRDJ désirent exprimer conjointement leur déception après avoir reçu copie d’un courriel interne de l’Agence du revenu du Canada (ARC) qui démontre qu’une [...]

Vascular Dynamics Appoints Ed Roschak CEO

04/12/2017 - 15:45

MOUNTAIN VIEW, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today [...]

Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS)

04/12/2017 - 15:05

SABCS to include five abstracts from the development program for elacestrant as a potential treatment of ER-positive advanced breast cancer Radius to host live webcast to discuss data presented at SABCS and provide a [...]

La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients with Beta Thalassemia

04/12/2017 - 15:00

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of a pivotal clinical study of LJPC‑401 (synthetic human hepcidin) in [...]

Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%

04/12/2017 - 14:35

PURCHASE, NY, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ) the world’s largest and most trusted provider of virtual care delivery services, today announced record growth of greater than 100% in the [...]

Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions

04/12/2017 - 14:30

DAVIS, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]

Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer

04/12/2017 - 14:30

VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies

04/12/2017 - 14:30

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

FDA Selects HemoStyp® for CtQ Pilot Program

04/12/2017 - 14:30

HENDERSON, Nev., Dec. 04, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Uptick Newswire “Stock Day” Interviews CEO of Progressive Care on the Completed Success in the Pharmaceutical Industry

04/12/2017 - 14:30

Miami, FL , Dec. 04, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire “Stock Day” host Everett Jolly warmly welcomes back a long awaited guest Shital Mars, CEO of Progressive Care Inc. (OTCPink: RXMD) (“Progressive Care” or the [...]

Canadian Blood Services board meeting open to the public

04/12/2017 - 14:00

OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- On Dec. 7, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]

La réunion du conseil d’administration de la Société canadienne du sang ouverte au public

04/12/2017 - 14:00

OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion de son conseil d’administration. La réunion aura lieu le 7 décembre à Ottawa [...]

CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel

04/12/2017 - 14:00

NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel

04/12/2017 - 14:00

NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab Inc.

04/12/2017 - 14:00

VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce that it has entered into a share purchase agreement [...]

CorVel Successfully Implements CareMC Edge

04/12/2017 - 14:00

IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL ) announced today the successful implementation of their CareMC Edge data integration tool for the insurance carrier marketplace. [...]

The American Health Council Physician Board Welcomes Indrani Hightower, MD

04/12/2017 - 14:00

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Indrani Sen Hightower, MD as an affiliate of its Physician Board. She has spent the last two years as a Neurologist at [...]

XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology

04/12/2017 - 14:00

AUSTIN, Texas, Dec. 04, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today the publication of data from its randomized phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment [...]

Emblem Corp. Provides Business Update for 2018

04/12/2017 - 14:00

TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically integrated cannabis company focused on research, development, production and distribution of cannabis [...]